NRG-GY014 – Temporarily Closed

A Phase II Study Of Tazemetostat (EPZ-6438) (IND # 138671) In Recurrent Or Persistent Endometrioid Or Clear Cell Carcinoma Of The Ovary, And Recurrent Or Persistent Endometrioid Endometrial Adenocarcinoma

For more information about this clinical trial, click here

Schema & Eligibility NRG-GY014

Available at:

CoxHealth Medical Center, Springfield, MO
Mercy Hospital, Springfield, MO
Mercy Hospital, St. Louis, MO

Ask your physician about participating in this clinical trial or call us.